Baseline | Follow-up | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Sex | Age | Current asthma | FEV1 post EVHa | CLE score glottic + supraglottic | EID | Months between visits | Current asthma | FEV1 post EVHa | CLE score glottic + supraglottic | EID |
Male | 17 | Yes | -2.7 | 1 + 1 | No | 3 | Yes | -2.6 | 1 + 1 | No |
Female | 16 | No | -8.3 | 0 + 1 | No | 9 | No | -8.4 | 0 + 1 | No |
Female | 18 | No | -3.4 | 0 + 1 | No | 9 | No | -3.7 | 0 + 1 | No |
Male | 17 | No | -3.6 | 0 + 1 | No | 4 | No | 0.0 | 0 + 2 | No |
Female | 23 | Yes | -6.0 | 0 + 1 | No | 10 | Yes | -5.9 | 0 + 0 | No |
Female | 19 | No | -3.4 | 0 + 1 | No | 8 | No | -2.4 | 0 + 2 | No |
Female | 24 | No | -7.0 | 0 + 1 | Yes | 11 | No | -5.3 | 0 + 1 | No |
Male | 19 | No | -3.4 | 0 + 1 | No | 6 | No | -3.4 | 0 + 1 | No |
Male | 19 | Yes | -12.7 | 0 + 1 | No | 6 | Yes | -2.2 | 0 + 1 | Yes |
Male | 16 | No | -9.2 | 0 + 1 | Yes | 6 | No | < -10.0b | 0 + 1 | No |
Male | 17 | Yes | -1.6 | 0 + 1 | No | 8 | Yes | -2.9 | 0 + 1 | No |
Male | 27 | No | -5.6 | 0 + 1 | No | 21 | No | -12.1 | 0 + 2 | No |
Male | 18 | No | -13.0 | 0 + 1 | No | 6 | Yes | -10.5 | 0 + 0 | No |
Male | 16 | No | -3.1 | 0 + 0 | No | 8 | No | -7.0 | 0 + 1 | No |
Male | 19 | No | -4.4 | 0 + 0 | No | 5 | No | < -10.0b | 0 + 0 | No |
Male | 18 | Yes | -3.4 | 0 + 0 | Yes | 3 | Yes | < -10.0b | 0 + 0 | Yes |
Male | 18 | No | -9.5 | 0 + 0 | No | 7 | No | -6.5 | 0 + 1 | No |
Male | 20 | No | -3.3 | 0 + 0 | No | 13 | No | 1.4 | 0 + 0 | No |